Header image

Transforming Global Genetic Data into Medical Decisions

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Latest Scientific News

Personalizing Therapeutic Decisions in Fabry Disease

More than a single treatment option is available for some genetic disorders. For Fabry…

A Novel Neurodevelopmental Disorder

Brain development is a highly complex process involving numerous proteins. The latest…

Frequent Genetic Cause of Seizures Identified

The etiology of seizures is highly heterogeneous and involves an unknown number of…

Generation of iPSCs for Rare Diseases

Induced pluripotent stem cells (iPSCs) represent excellent in vitro models to study rare…

Moving Towards New Therapies for Fabry Disease

Fabry disease is a multi-system lysosomal storage disorder. As it is caused by an enzyme…

Understanding DNA Alterations in Colorectal Cancer

Germline and somatic DNA alterations may cause inherited diseases and/or cancer. While…

A Novel Genetic Syndrome

Standard genome-scale diagnostics fail to identify a pathogenic variant in up to 50% of…

Understanding Neurodegeneration in Niemann-Pick Disease

Niemann-Pick (NP) disease is a lysosomal storage disorder that involves the degeneration…

Characterization of an Ultra-Rare Disorder

Novel gene-disease associations are continuously being proposed, but the underlying…

An Unorthodox Disease Mechanism

Essential proteins are defined as those that are necessary for living. In theory,…

Customer Feedback

Give feedback

Newsletter subscription

Supporting rare disease diagnosis, education, and clinical research

Read more

Driving Accelerated Diagnosis and Treatment Development

Read more

Driving personalized, immune-based therapy to target patients’ own immune responses

Read more

Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database

Read more

Artificial Intelligence verbessert die Diagnose seltener Erkrankungen, basierend auf der weltweit größten kuratierten Mutationsdatenbank

Read more

Research findings may provide deeper understanding on the role of genes that can contribute to development of Hypophosphatasia.

Read more

In a whitepaper released today, CENTOGENE provided an update on its induced pluripotent stem cells (iPSC) program.

Read more

CENTOGENE today welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of...

Read more